Results 261 to 270 of about 116,117 (334)

Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections. [PDF]

Front Pharmacol
Fukaya-Shiba A, Ogata A, Kuribayashi R, Sakurai A, Suzuki K, Takadama S, Nishimura J, Uchiyama J, Ohge H, Takeuchi T, Tamaki H, Matsumoto T, Kiga K, Iwano H.   +13 more
europepmc   +1 more source

Self‐Assembly of Anti‐Inflammatory Peptide Amphiphiles for Mucosal Health

ChemBioChem, Volume 27, Issue 7, 14 April 2026.
Self‐assembled peptide amphiphiles with mucosal surface targeting capabilities represent a novel strategy to promote human mucosal tissue health through enhanced delivery of anti‐inflammatory and antiviral peptides at mucosal sites. Broad spectrum anti‐inflammatory peptide amphiphiles (AIF‐PAs) have been developed as an innovative strategy for the ...
María José Gómara, Ignacio Pérez‐Pomeda, Ramon Pons, Paul Ziprin, Carolina Herrera, Isabel Haro   +5 more
wiley   +1 more source

Genomic, Evolutionary and Phenotypic Insights into Pseudomonas Phage Adele, a Novel Pakpunavirus with Potential for Phage Therapy. [PDF]

Viruses
Chaplin AV, Skvortsov GA, Sykilinda NN, Troshin KS, Vasilyeva AA, Malkov AA, Leont'eva MR, Miroshnikov KA, Yaitsky MA, Shagin DA, Efimov BA, Kafarskaia LI, Komarevtsev SK, Evseev PV.   +13 more
europepmc   +1 more source

A theoretical framework for an integrated public-private approach to address the AMR crisis with phage therapy: a thought experiment

Sebastián Leptihn, Belinda Loh
openalex   +2 more sources

Enzyme‐Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors

ChemBioChem, Volume 27, Issue 7, 14 April 2026.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important therapeutic target for lowering cholesterol. Here, we report the assembly of a bifunctional molecule combining a PCSK9‐binding peptide with an asialoglycoprotein receptor (ASGPR) ligand.
Yuhui Zhang, Li Wang, Leo Corcilius, Amal K. Reji, Richard J. Payne, Bin Hong, Thomas Durek, Conan K. Wang, David J. Craik   +8 more
wiley   +1 more source

Microbial keratitis in the age of resistance: unlocking the therapeutic potential of phage therapy. [PDF]

Graefes Arch Clin Exp Ophthalmol
Ibrahim R, Kumar P, Aranjani JM.
europepmc   +1 more source

Phage therapy of perinephric abscess in kidney transplantation recipients caused by drug-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

mLife
Liu J, Lu S, Bao J, Wang J, Gong Y, He B, Zhu Y, Zhong Z, Li S, Li L, Li N, Cheng M, Li M, Shen M, Wu N, Zhu T, Le S.   +16 more
europepmc   +1 more source

Impact of phage therapy in post-weaning piglets challenged with ETEC strain in a controlled minitrial

Md Rayhan Mahmud, Md Karim Uddin, Peppi Kareljärvi, Matti Jalasvuori, Juuli Peräkylä, Tiia Eklund, Mia Biström, Shah Hasan, Tommi Vatanen, Saija Kiljunen, Claudio Oliviero   +10 more
openalex   +1 more source

Optimizing phage therapy with artificial intelligence: a perspective. [PDF]

Front Cell Infect Microbiol
Doud MB, Robertson JM, Strathdee SA.
europepmc   +1 more source

Phage Therapy as a Novel Alternative to Antibiotics Through Adaptive Evolution and Fitness Trade-Offs. [PDF]

Antibiotics (Basel)
Zhang S, Ahn J.
europepmc   +1 more source